Rhinosinusitis: Evidence and experience – 2024

It has been 10-years since the publication of Rhinosinusitis: evidence and experience, and since then a lot has changed in our understanding of the disease. Advances in pathophysiology, endotyping and new treatments such as biologics brought a new era in the management of our patients. This new guideline, developed jointly by ABR and ABORL-CCF, with the help of ASBAI presents an updated, evidence-based approach to the different forms of rhinosinusitis that aims to improve the diagnosis and treatment of this complex disease. The document covers a wide range of topics, including clear definitions of the different stages of acute sinusitis. It also introduces a new term called Prolonged Acute Viral Rhinosinusitis. Reviews phenotypes and endotypes of chronic rhinosinusitis, recommending methods for clinical and laboratory investigation, clinical and surgical treatment. We also discuss in detail fungal sinusitis and pediatric sinusitis. The objective of this updated Consensus is to clarify some already established and recent concepts, highlighting the importance of an accurate diagnosis to promote treatment approaches that reflect the best practices based on solid evidence. Therefore, we seek not only to improve the results of patients care, but also to guide thealth professionals through a clinical panorama that is in constant transformation.

Authors

Institutions

Publication Details

Journal
Brazilian Journal of Otorhinolaryngology
Published
2025-05-19
DOI
https://doi.org/10.1016/j.bjorl.2025.101595
Citations
1
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
1.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rhinosinusitis: Evidence and experience – 2024

Thiago Freire Pinto Bezerra, José Laerte Boechat, Vanessa Ramos Pires Dinarte, Fabrizio Ricci Romano et al.
1 citations
Brazilian Journal of Otorhinolaryngology
Sinusitis and nasal conditions
1.85
article

Rhinosinusitis: Evidence and experience – 2024

Thiago Freire Pinto Bezerra, José Laerte Boechat, Vanessa Ramos Pires Dinarte, Fabrizio Ricci Romano, Faradiba Sarquis Serpa, Ricardo Landini Lutaif Dolci, Carolina Cincurá Barreto, Marcel M. Miyake, Fábio Chigres Kuschnir, Mariana Dalbo Contrera Toro, Wilma Terezinha Anselmo‐Lima, Alexandre Felippu, Norma de Paula Motta Rubini, Fabiana Cardoso Pereira Valera, Eduardo Macoto Kosugi, Eulália Sakano, Ekaterini Goudouris, Richard Louis Voegels, Olavo Mion, Gustavo Subtil Magalhães Freire, João Ferreira de Mello, Sérgio Duarte Dortas, Otávio Bejzman Piltcher, Renato Roithmann, Márcio Nakanishi, Miguel Soares Tepedino, Marcus Miranda Lessa, Edwin Tamashiro, Marco Aurélio Fornazieri, Camila Degen Meotti, Dirceu Solé, Gabriela Ricci Luz‐Matsumoto, Roberto Eustáquio Santos Guimarães, Fábio de Rezende Pinna, Shirley Pignatari, Leonardo Lopes Balsalobre Filho
article en
1 citations

Abstract

It has been 10-years since the publication of Rhinosinusitis: evidence and experience, and since then a lot has changed in our understanding of the disease. Advances in pathophysiology, endotyping and new treatments such as biologics brought a new era in the management of our patients. This new guideline, developed jointly by ABR and ABORL-CCF, with the help of ASBAI presents an updated, evidence-based approach to the different forms of rhinosinusitis that aims to improve the diagnosis and treatment of this complex disease. The document covers a wide range of topics, including clear definitions of the different stages of acute sinusitis. It also introduces a new term called Prolonged Acute Viral Rhinosinusitis. Reviews phenotypes and endotypes of chronic rhinosinusitis, recommending methods for clinical and laboratory investigation, clinical and surgical treatment. We also discuss in detail fungal sinusitis and pediatric sinusitis. The objective of this updated Consensus is to clarify some already established and recent concepts, highlighting the importance of an accurate diagnosis to promote treatment approaches that reflect the best practices based on solid evidence. Therefore, we seek not only to improve the results of patients care, but also to guide thealth professionals through a clinical panorama that is in constant transformation.

Brazilian Journal of OtorhinolaryngologyVol. 91(5)
Universidade Federal de Minas Gerais (BR), Universidade Federal do Rio de Janeiro (BR), Universidade Federal da Bahia (BR), Universidade Estadual de Londrina (BR), Universidade Federal do Rio Grande do Sul (BR), Universidade de Ribeirão Preto (BR), Universidade de Brasília (BR), Faculdade de Medicina de Marília (BR), Universidade Federal Fluminense (BR), Universidade de São Paulo (BR), Universidade Estadual de Campinas (UNICAMP) (BR), Universidade Federal de Pernambuco (BR), Universidade do Estado do Rio de Janeiro (BR), Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (BR), Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR), Faculdade de Medicina de Petrópolis (BR), Hospital Universitário de Brasília (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Universidade Luterana do Brasil (BR), Universidade Federal de São Paulo (BR)
Openalex Percentile: Top 16%
Sinusitis and nasal conditions
1.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.